article graphic

News & insights

Filter by:

Filters

Synapse - Post market activities including PMS and product liability

Drafting PMS and vigilance obligations into medical device distribution agreements

In this article we discuss here how manufacturers might ensure, through appropriate contractual provisions, that distributors (and importers) will provide all necessary support to allow a manufacturer to comply with its PMS obligations.

17 July 2025
Briefing

by Alison Dennis

6 of 6 Insights

Click here to find out more
Synapse - Post market activities including PMS and product liability

Product Liability Directive: Are you ready for its Article 9 disclosure obligations?

The New EU Directive on Liability for Defective Products modernises the current EU legislation to bring it up to date with our ever-evolving digital environment. One particularly significant change is the extended disclosure burden. In this article we examine why this burden is particularly difficult for multi-national life sciences businesses and explain the steps you should be taking now to mitigate against potential court sanctions for failure to disclose relevant evidence.

17 July 2025
Briefing

by Max Kempe

3 of 6 Insights

Click here to find out more
Synapse - Post market activities including PMS and product liability

A new era for product liability in the EU

This article outlines the key changes introduced by the new PLD. It explores the expanded scope of liability and the broader pool of potentially liable parties, as well as the new rules on the burden of proof and disclosure of evidence.

17 July 2025
Briefing

by multiple authors

1 of 6 Insights

Click here to find out more
Synapse - Post market activities including PMS and product liability

Insights from Member States: What can we expect from the new Product Liability Directive?

The new Product Liability Directive introduces significant changes to the EU’s product liability regime in the EU. Member States must implement it by December 2026. But what will its biggest challenges be? How can businesses prepare for and mitigate the new product liability risks in the EU?

17 July 2025
Briefing

by multiple authors

2 of 6 Insights

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Corporate/M&A & capital markets

Taylor Wessing advises General Catalyst, Lightspeed and Accel on €600 million financing of Helsing

17 July 2025

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Brands & advertising

German Environment Agency (Umweltbundesamt, UBA) prohibits German long-distance bus company from advertising in Belgium with the terms “climate-friendly” and “environmentally neutral”

16 July 2025
Briefing

by Andreas Bauer

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Environmental, social & governance (ESG)

The EU Urban Wastewater Treatment Directive

15 July 2025
Briefing

by Dr. Kris Breudel, LL.M. (Aberdeen)

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Energy & infrastructure

New Legal Framework for the Commercial Use of Carbon Capture and Storage (CCS) and Carbon Capture and Utilisation (CCU)

11 July 2025
Briefing

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Life sciences & healthcare

Court Rulings on Pharmacy Marketing Remain Strict: OLG Frankfurt Prohibits Voucher Advertising

9 July 2025
Quick read

by Kathleen Munstermann-Senff, LL.M. (Medical Law) and Dr. Daniel Tietjen

Click here to find out more
Call To Action Arrow Image

Events

Hear from our experts as they discuss the latest legal issues.

Browse our events
Browse our events